Search results for "Progression"

showing 10 items of 1251 documents

Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.

2014

Importance There is an urgent need to identify reliable biomarkers of amyotrophic lateral sclerosis (ALS) progression for clinical practice and pharmacological trials. Objectives To correlate several hematological markers evaluated at diagnosis with ALS outcome in a population-based series of patients (discovery cohort) and replicate the findings in an independent validation cohort from an ALS tertiary center. Design, Setting, and Participants The discovery cohort included 712 patients with ALS from the Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis from January 1, 2007, to December 31, 2011. The validation cohort comprised 122 patients with ALS at different stages of…

MaleanalysisGastroenterologyCohort Studieschemistry.chemical_compoundAdult Aged Aged; 80 and over Amyotrophic Lateral Sclerosis; blood/mortality/pathology Biological Markers; blood Cohort Studies Creatinine; blood Disease Progression Female Humans Italy Lymphocyte Count Male Middle Aged Outcome Assessment (Health Care) Predictive Value of Tests Prognosis Sensitivity and Specificity Serum Albumin; analysisblood/mortality/pathologyOutcome Assessment Health Care80 and overAged 80 and overeducation.field_of_studybiologymedicine.diagnostic_testHazard ratioMiddle AgedPrognosisItalyErythrocyte sedimentation rateCreatinineCohortDisease ProgressionSettore MED/26 - NeurologiaBiological MarkersFemaleCohort studyAdultmedicine.medical_specialtyPopulationSerum albuminSensitivity and SpecificityOutcome Assessment (Health Care)bloodPredictive Value of TestsInternal medicinemedicineHumansLymphocyte CounteducationSerum AlbuminAgedCreatininebusiness.industryAmyotrophic Lateral SclerosisAlbuminchemistryImmunologybiology.proteinNeurology (clinical)ALSbusinessBiomarkersJAMA neurology
researchProduct

Osmophobia as an early marker of migraine: a follow-up study in juvenile patients.

2012

Background: Osmophobia is frequent in children with migraine (20–35%) but can also occur in up to 14% of cases with tension-type headache (TTH). So far, the prognostic role of this symptom in children with primary headaches has never been evaluated. Methods: A longitudinal prospective study was conducted on 90 young patients with TTH (37 with osmophobia, 53 without osmophobia). We evaluated whether osmophobia could predict the diagnosis transformation from TTH to migraine after a 3-year follow-up. Results and Discussion: In our cases the rate of diagnosis change was significantly greater in cases with osmophobia (62%) than in those without (23%). Osmophobia persisted at a 3-year follow-up …

Malechildren; follow-up; migraine without aura; Osmophobia; tension-type headachePediatricsmedicine.medical_specialtyAdolescentMigraine DisordersComorbidityRisk AssessmentPhobic disorderOlfaction DisorderschildrenRisk Factorsosmophobia; juvenile primary headache; migraine without aura; tension-type headachePrevalencefollow-upHumansMedicineJuvenileSex DistributionChildbusiness.industryOsmophobiaDisease progressionFollow up studiesGeneral Medicinemedicine.diseaseComorbiditytension-type headacheCausalityOsmophobiaEarly Diagnosisjuvenile primary headacheItalyPhobic DisordersMigrainemigraine without auraDisease ProgressionPhysical therapyFemaleNeurology (clinical)businessFollow-Up Studies
researchProduct

Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density.

2001

Thrombospondin-1 (TSP-1) is a multifunctional platelet and extracellular matrix protein that is involved in angiogenesis. Under certain pathological conditions, e.g., malignant tumors, high concentrations of TSP-1 work as an angiogenic agonist. Here we examined 98 pancreatic carcinomas with respect to TSP-1 immunoreactivity and its correlation to intratumoral microvessel density (MVD), a representation of the overall degree of angiogenesis in carcinomas. Northern blot analysis for TSP-1 mRNA was performed in seven additional cases. Eighty-seven tumors showed strong TSP-1 immunoreactivity, nine carcinomas were only weakly positive, and two lesions were negative for TSP-1. TSP-1 immunoreactiv…

Maleendocrine systemPathologymedicine.medical_specialtyPancreatic diseaseAngiogenesisGene ExpressionBiologyAdenocarcinomaPathology and Forensic MedicineNeovascularizationThrombospondin 1immune system diseasesThrombospondin 1medicineBiomarkers TumorHumansRNA MessengerMolecular BiologyAgedAged 80 and overNeovascularization PathologicMicrocirculationvirus diseasesCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseBlotting NorthernImmunohistochemistryBlotPancreatic Neoplasmsmedicine.anatomical_structureTumor progressionAdenocarcinomaFemalemedicine.symptomPancreasVirchows Archiv : an international journal of pathology
researchProduct

Red blood cell plasmalogens and docosahexaenoic acid are independently reduced in primary open-angle glaucoma

2009

International audience; Among several theories involved in the pathogenesis of primary open-angle glaucoma (POAG), the vascular theory considers the disease to be a consequence of reduced ocular blood flow associated with red blood cell abnormalities. Red blood cell membrane structure and function are influenced by their phospholipid composition. We investigated whether specific lipid entities that may affect the membrane physiology, namely, polyunsaturated fatty acids (PUFAs) and plasmalogens, are modified in POAG and whether these potential variations are related to the stage of glaucoma. Blood samples were collected from 31 POAG patients and 10 healthy individuals. The stage of glaucoma …

Malegenetic structuresGlaucomaPathogenesischemistry.chemical_compound0302 clinical medicine[SDV.IDA]Life Sciences [q-bio]/Food engineeringETHER-LIPIDSERYTHROCITEchemistry.chemical_classificationAged 80 and over0303 health sciencesMiddle AgedSensory Systemsmedicine.anatomical_structureBiochemistryDocosahexaenoic acidDisease ProgressionFemalelipids (amino acids peptides and proteins)Glaucoma Open-AnglePolyunsaturated fatty acidmedicine.medical_specialtySpectrometry Mass Electrospray IonizationOpen angle glaucomaDocosahexaenoic AcidsPhospholipidBiology03 medical and health sciencesCellular and Molecular NeuroscienceInternal medicinemedicineHumans[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringPLASMALOGENSPRIMARY OPEN-ANGLE GLAUCOMA (POGA)030304 developmental biologyAgedErythrocyte MembraneBlood flowDOCOSAHEXAENOIC ACID (DHA)medicine.diseaseeye diseasesOphthalmologyRed blood cellEndocrinologychemistryCase-Control Studies030221 ophthalmology & optometrysense organsVisual FieldsChromatography Liquid
researchProduct

Anisometropia of spherical equivalent and astigmatism among myopes: a 23-year follow-up study of prevalence and changes from childhood to adulthood.

2017

Purpose To study anisometropia of spherical equivalent and astigmatism from the onset of myopia at school age to adulthood. Methods A total of 240 myopic schoolchildren (mean age 10.9 years), with no previous spectacles, were recruited during 1983–1984 to a randomized 3-year clinical trial of bifocal treatment of myopia. Examinations with subjective cyclopedic refraction were repeated 3 years later (follow-up 1) for 238 subjects and thereafter at the mean ages of 23.2 (follow-up 2) and 33.9 years (follow-up 3) for 178 and 134 subjects. After exclusions, the 102 subjects who attended all three follow-ups were included in the analyses. Corneal refractive power and astigmatism and anterior cha…

Malegenetic structuresemmetropizationtaittovirheetSpherical equivalentAnisometropiaCornea0302 clinical medicineCornearefractive errorsMyopiaPrevalenceMedicineChildFinlandSchool age childFollow up studiesGeneral MedicineAxial lengthta3142follow-up studyAxial Length Eyemedicine.anatomical_structureEyeglassesDisease ProgressionFemaleseurantatutkimusanisoastigmatismAdultmedicine.medical_specialtyAdolescentlikinäköisyysaxial lengthAstigmatismRefraction Ocular03 medical and health sciencesYoung AdultOphthalmologyHumansAnisometropiabusiness.industryAstigmatismCorneal Topographymedicine.diseaseeye diseasesta3125Ophthalmology030221 ophthalmology & optometrybusinessCorneal astigmatism030217 neurology & neurosurgeryFollow-Up StudiesForecastingActa ophthalmologica
researchProduct

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting …

2010

The objective of this study was to assess the effects of subcutaneous (sc) interferon beta-1a (IFNβ-1a) on cognition in mildly disabled patients with relapsing—remitting multiple sclerosis (RRMS). Patients aged 18—50 years with RRMS (McDonald criteria; Expanded Disability Status Scale score ≤4.0) were assigned IFNβ therapy at the physician’s discretion and underwent standardized magnetic resonance imaging, neurological examination and neuropsychological testing at the baseline and regular intervals for up to three years. This analysis included 459 patients who received sc IFNβ-1a (44 mcg: n = 236; 22 mcg: n = 223; three-year follow up was available for 318 patients). The hazard ratio for c…

Maleinterferon beta-1aKaplan-Meier EstimateRelapsing-RemittingNeuropsychological TestsCohort StudiesDisability EvaluationMedicineMale; Adolescent; Young Adult; Middle Aged; Kaplan-Meier Estimate; Cognition Disorders; Survival Analysis; Female; Disability Evaluation; Dose-Response Relationship Drug; Humans; Multiple Sclerosis Relapsing-Remitting; Prospective Studies; Cohort Studies; Disease Progression; Interferon-beta; Injections Subcutaneous; Neuropsychological Tests; Adult; Immunologic Factors; Endpoint DeterminationProspective StudiesProspective cohort studyinterferon beta multiple sclerosis cognitive impairmentSubcutaneousCognitive disorderHazard ratioMiddle AgedSettore MED/26 - NEUROLOGIANeurologyDisease ProgressionSettore MED/26 - NeurologiaFemaleDrugmedicine.drugAdultmedicine.medical_specialtyMultiple SclerosisAdolescentEndpoint DeterminationInjections SubcutaneousLower riskInjectionsDose-Response RelationshipYoung AdultMultiple Sclerosis Relapsing-RemittingInternal medicineHumansImmunologic Factorscognitive functioncognitive impairmentExpanded Disability Status ScaleDose-Response Relationship Drugbusiness.industryInterferon beta-1aMcDonald criteriaOdds ratioInterferon-betamedicine.diseaseSurvival AnalysisSurgerydisabilityNeurology (clinical)businessCognition Disorderscognitive function; cognitive impairment; disability; disease progression; interferon beta-1a; multiple sclerosis
researchProduct

Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline

2020

Abstract Background Left ventricular ejection fraction (LVEF) trajectories and functional recovery with current heart failure (HF) management is increasingly recognized. Type 2 diabetes mellitus (T2D) leads to a worse prognosis in HF patients. However, it is unknown whether T2D interferes with LVEF trajectories. The aim of this study was to prospectively assess very long-term (up to 15 years) LVEF trajectories in patients with and without T2D and underlying HF. Methods Ambulatory patients admitted to a multidisciplinary HF clinic were prospectively evaluated by scheduled two-dimensional echocardiography at baseline, 1 year, and then every 2 years afterwards, up to 15 years. Statistical anal…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyEjection fractionTime FactorsEtiologyDiabetic CardiomyopathiesEndocrinology Diabetes and MetabolismHeart failureType 2 diabetesVentricular Function LeftVentricular Dysfunction LeftDiabetes mellitusLong-termRisk FactorsInternal medicineDiabetes mellitusDiabetic cardiomyopathymedicineHumansProspective StudiesOriginal InvestigationAngiologyAgedHeart FailureEjection fractionbusiness.industryFollow-upType 2 Diabetes MellitusStroke VolumeMiddle Agedmedicine.diseaseProgression-Free SurvivalDiabetes Mellitus Type 2lcsh:RC666-701Heart failureAmbulatoryDisease ProgressionFemaleCardiology and Cardiovascular Medicinebusiness
researchProduct

Nutritional predictors of cognitive impairment severity in demented elderly patients: The key role of BMI

2012

Introduction: The body mass index (BMI) is commonly used to assess nutritional status and the Mini Mental State Examination (MMSE) is a validated tool for assessing cognitive status in elderly people. Nutritional and cognitive aspects are closely related in dementia. Objectives: To establish whether BMI predicts cognitive decline in demented patients and whether an "alarm" BMI cut-off exists for declining MMSE scores. Subjects and methods: 82 elderly demented patients underwent clinical, bio-chemical and functional assessment. Design: Transversal study. Results: The mean BMI was 26.08±4.48 kg/m 2 and the mean MMSE 18.68±5.38. Patients with BMI>25 kg/m2 had significantly lower MMSE scores…

Malemedicine.medical_specialtyActivities of daily livingMedicine (miscellaneous)Nutritional StatusLogistic regressionSeverity of Illness IndexInternal medicineSeverity of illnessActivities of Daily LivingmedicineDementiaHumansMass indexCognitive declineGeriatric AssessmentBody mass indexAgedAged 80 and overPsychiatric Status Rating ScalesSex CharacteristicsNutrition and DieteticsMini–Mental State Examinationmedicine.diagnostic_testbusiness.industrymedicine.diseaseDietVitamin B 12Logistic ModelsNutrition AssessmentItalyPhysical therapyDisease ProgressionDementiaFemaleGeriatrics and GerontologybusinessCognition DisordersBody mass index
researchProduct

TELEPHONE FOLLOW-UP FOR PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS

2007

The relentless evolution of amyotrophic lateral sclerosis (ALS), a severe neurodegenerative disorder of the upper and lower motoneurons, leads to an increasing level of disability. Most patients, during the course of the disease, become unable to attend the tertiary clinical care center and are thus prevented from enrolling in clinical trials or benefiting from specialized care and management. The main objective of this study was to verify whether the ALS functional rating scale (ALSFRS) could be reliably administered by telephone to patients, when unable to attend the ALS clinic, or to their caregivers. ALSFRS is a validated instrument that assesses the functional status and the disease pr…

Malemedicine.medical_specialtyAdaptive equipmenttelephone interviewDiseaseSeverity of Illness IndexInterviews as Topicdisease progressionSwallowingRating scaleActivities of Daily LivingSeverity of illnessmedicineHumansamyotrophic lateral sclerosiAmyotrophic lateral sclerosisAgedbusiness.industryMiddle Agedamyotrophic lateral sclerosis functional rating scalemedicine.diseaseClinical trialCaregiversNeurologyTelephone interviewPhysical therapyFemaleAMYOTROPHIC LATERAL SCLEROSISNeurology (clinical)businessFollow-Up Studies
researchProduct

MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarism.

2007

Aim: To evaluate the relationship between pituitary size, PIT1 and PROP1 genotype, and the severity of childhood onset growth hormone deficiency (coGHD). Patients: Forty-four patients with coGHD (34 M; 9.7 ± 4.1 years): severe isolated (SI) GHD (n = 14); partial isolated (PI) GHD (n = 13); multiple pituitary hormone deficiencies (MPHD) (n=17). Results: Pituitary abnormalities were found in 7/14 patients with SIGHD (50%), 16/17 patients with MPHD (94.1%), and no patient with PIGHD. Mean pituitary height (PHT SDS) was significantly lower in MPHD than in SIGHD and PIGHD. Pituitary height SDS and pituitary volume (PV) SDS correlated with IGF-I SDS and stimulated GH peaks in the SIGHD and MPHD g…

Malemedicine.medical_specialtyAdolescentGenotypeEndocrinology Diabetes and MetabolismGenotype AnalysisHypopituitarismHypopituitarismGrowth hormone deficiencyCorrelationEndocrinologyInternal medicineAge Determination by SkeletonGenotypemedicineHumansIn patientAge of OnsetChildDwarfism PituitaryRetrospective StudiesHomeodomain Proteinsbusiness.industrymedicine.diseaseMagnetic Resonance ImagingBody HeightEndocrinologyChild PreschoolPituitary GlandPediatrics Perinatology and Child HealthPituitary hormonesDisease ProgressionFemalebusinessTranscription Factor Pit-1Mri findingsJournal of pediatric endocrinologymetabolism : JPEM
researchProduct